The European Joint Programme on Rare Diseases invites applications for its rare diseases research challenges.
These facilitate and fund collaboration between industry, academia, SMEs, and patient organisations to solve specific research challenges in rare diseases. It is expected that the creation of new partnerships will enable access to scientific and technological innovations emerging from SMEs and academic research groups for industry and provide a facilitated pathway for academics to exploit their research. The challenges are:
- development of a non-invasive tool for measuring rare disease patient mobility in daily living;
- development of a delivery system for intranasal administration of biological drugs to neonates;
- characterisation of rare bone disorders mobility challenges in real world setting;
- development and validation of a preclinical assay to detect instability of microsatellite repeat expansions.
Collaborative consortia consisting of partners from academia, the clinical and public health sector, SMEs and patient advocacy organisations may apply. Consortia must consist of at least two and up to six eligible applicants from at least two different countries participating in the European Joint Programme on Rare Diseases.
The total budget is worth €1.5 million.
Four grants, worth €375,000 each, are available for up to 30 months.
Deadline: June, 30 2020